The pharmaceutical company Grifols will create 200 new jobs at its Dublin site

Grifols has invested around 300 million euros in its Irish operations since 2012. It is now looking to increase the workforce of its Dublin site to 500.

Pharmaceutical company Grifols is expanding its presence in Dublin, with the inauguration of a new specialist factory and a plan to create up to 200 jobs.

Grifols currently employs over 300 people at its global manufacturing and supply center in Dublin. It plans to increase its workforce at the site to around 500 in the next two years.

It will hire for entry-level and specialized positions in manufacturing, logistics and packaging. Positions currently on offer in Dublin include QC Microbiologist, Validation Engineer, Manufacturing Fill Process Technician and Maintenance Automation Engineer.

Grifols is a Spanish multinational specialized in plasma-derived medicines. Today (October 19), the company officially opens its new albumin purification and filling plant at its existing Dublin site.

The new plant will triple the annual production capacity of filling the company’s flexible container, the Albutein FlexBag. This container delivers albumin – a protein made by the liver and found in plasma – to patients. It also provides a means of storing and transporting albumin, for which global demand is expected to increase over the next few years.

Albumin is used to replace lost fluids, restore vital blood volume and treat conditions such as cirrhosis. Grifols also advances its potential use to treat neurological degenerative disorders.

“This magnificent new manufacturing facility in Dublin, which incorporates Grifols’ state-of-the-art engineering, demonstrates this company’s commitment to investing in critical plasma medicine infrastructure globally to treat more patients in the world. world,” said Víctor Grifols Deu and Raimon Grifols, Grifols’ co-CEOs.

Grifols established operations in Ireland in 2012 and has invested around €300m in its Dublin hub since then. In 2015, it injected 90 million euros into the Grange Castle site, creating 140 jobs.

“I warmly welcome Grifols’ continued investment in Ireland and the additional 200 jobs this will bring to Dublin,” said Tánaiste and Minister for Enterprise, Trade and Employment Leo Varadkar, TD.

“Having steadily increased its presence in Ireland over the past decade, Grifols’ continued expansion strengthens Dublin as an important center of the company’s global operations. This is further evidence of Ireland’s role as a major hub for biopharmaceutical and international trade, with a highly talented workforce available.

In addition to the Dublin site, the company has four other essential plasma drug manufacturing bases in Barcelona, ​​North Carolina, California and Germany.

More information about careers at Grifols can be found on its website.

10 things you need to know straight to your inbox every weekday. Sign up for the brief dailythe summary of essential science and technology news from Silicon Republic.

Leave a Reply